ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

OVID Company Profile and Key Details

NASDAQ : OVID

Ovid Therapeutics Inc.

$0.34

0.0303+9.78%

At Close 4:00 PM

$0.36

0.0170+5.00%

After-Market 08:30 PM

57.48

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

OVID Stock Price Chart

Stock Price Today

Ovid Therapeutics Inc. (OVID) stock surged +9.78%, trading at $0.34 on NASDAQ, up from the previous close of $0.31. The stock opened at $0.33, fluctuating between $0.32 and $0.35 in the recent session.

Stock Snapshot

0.3097

Prev. Close

0.33

Open

24.17M

Market Cap

71.08M

Number of Shares

0.3197

Day Low

0.3451

Day High

-0.92

P/E Ratio

79.67%

Free Float in %

-0.37

EPS (TTM)

1.24

Book Value

-0.65

Cash Flow per Share

154.65K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 02, 2025	0.33	0.35	0.32	0.34	166.66K
Apr 01, 2025	0.33	0.33	0.30	0.31	334.51K
Mar 31, 2025	0.35	0.36	0.31	0.31	2.44M
Mar 28, 2025	0.38	0.38	0.35	0.35	674.26K
Mar 27, 2025	0.40	0.41	0.37	0.38	497.27K
Mar 26, 2025	0.43	0.44	0.40	0.41	532.63K
Mar 25, 2025	0.46	0.48	0.43	0.43	314.21K
Mar 24, 2025	0.44	0.45	0.43	0.44	196.42K
Mar 21, 2025	0.42	0.46	0.42	0.43	371.5K
Mar 20, 2025	0.48	0.49	0.43	0.43	170.94K
Mar 19, 2025	0.45	0.48	0.45	0.48	413.8K
Mar 18, 2025	0.47	0.48	0.45	0.46	270.57K
Mar 17, 2025	0.46	0.48	0.43	0.47	283.19K
Mar 14, 2025	0.45	0.49	0.42	0.43	196.9K
Mar 13, 2025	0.55	0.55	0.44	0.44	271.95K
Mar 12, 2025	0.52	0.53	0.50	0.50	146.62K
Mar 11, 2025	0.51	0.51	0.46	0.49	166.33K
Mar 10, 2025	0.52	0.58	0.49	0.49	218.48K
Mar 07, 2025	0.51	0.54	0.51	0.52	172.71K
Mar 06, 2025	0.50	0.53	0.50	0.52	194.59K

Contact Details

New York, NY 10036

United States

Website: https://www.ovidrx.comContact: 646 661 7661

About Company

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, and Northwestern University, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.

Frequently Asked Questions

What is the current Ovid Therapeutics Inc. (OVID) stock price?

Ovid Therapeutics Inc. (NASDAQ: OVID) stock price is $0.34 in the last trading session. During the trading session, OVID stock reached the peak price of $0.35 while $0.32 was the lowest point it dropped to. The percentage change in OVID stock occurred in the recent session was 9.78% while the dollar amount for the price change in OVID stock was $0.03.

OVID's industry and sector of operation?

The NASDAQ listed OVID is part of Biotechnology industry that operates in the broader Healthcare sector. Ovid Therapeutics Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of OVID?

Dr. Matthew J. During DSc, FACP, FRACP, M.D., Ph.D.
Founder & Member of Scientific Advisory Board
Dr. Claude Nicaise M.D.
Head of R&D
Mr. Jason Tardio M.B.A.
Chief Operating Officer
Dr. Dirk Haasner
Senior Vice President of Global Manufacturing & CMC QA
Ms. Suzanne K. Wakamoto SHRM-SCP, SPHR
Senior Vice President of Culture & Facilities
Dr. Jeremy Max Levin Ba Zoology, Dphil, Mb Bchir
Pres, Chief Executive Officer & Chairman
Dr. Julia Tsai Ph.D.
Senior Vice President of Clinical Devel.
Mr. Simon D. Kelner
Chief HR Officer
Mr. Thomas Michael Perone J.D., M.B.A.
Gen. Counsel, Chief Compliance Officer & Corporation Sec.
Dr. Todd F. Baumgartner M.D., M.P.H.
Senior Vice President of Regulatory Affairs
Ms. Lora Pike
Vice President of Investor Relations & Communications
Dr. Todd F. Baumgartner M.P.H., M.D.
Senior Vice President of Regulatory Affairs, Pharmacovigilance & Biometrics
Mr. Jeffrey A. Rona
Principal Financial Officer, Principal Accounting Officer & Chief Bus. and Financial Officer

How OVID did perform over past 52-week?

OVID's closing price is 13.33% higher than its 52-week low of $0.30 where as its distance from 52-week high of $3.45 is -90.14%.

How many employees does OVID have?

Number of OVID employees currently stands at 23.

Link for OVID official website?

Official Website of OVID is: https://www.ovidrx.com

How do I contact OVID?

OVID could be contacted at phone 646 661 7661 and can also be accessed through its website. OVID operates from 1460 Broadway, New York, NY 10036, United States.

How many shares of OVID are traded daily?

OVID stock volume for the day was 154.65K shares. The average number of OVID shares traded daily for last 3 months was 431.99K.

What is the market cap of OVID currently?

The market value of OVID currently stands at $24.17M with its latest stock price at $0.34 and 71.08M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

OVID Stock Price Chart

Stock Price Today

Stock Snapshot

0.3097

Prev. Close

0.33

Open

24.17M

Market Cap

71.08M

Number of Shares

0.3197

Day Low

0.3451

Day High

-0.92

P/E Ratio

79.67%

Free Float in %

-0.37

EPS (TTM)

1.24

Book Value

-0.65

Cash Flow per Share

154.65K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 02, 2025	0.33	0.35	0.32	0.34	166.66K
Apr 01, 2025	0.33	0.33	0.30	0.31	334.51K
Mar 31, 2025	0.35	0.36	0.31	0.31	2.44M
Mar 28, 2025	0.38	0.38	0.35	0.35	674.26K
Mar 27, 2025	0.40	0.41	0.37	0.38	497.27K
Mar 26, 2025	0.43	0.44	0.40	0.41	532.63K
Mar 25, 2025	0.46	0.48	0.43	0.43	314.21K
Mar 24, 2025	0.44	0.45	0.43	0.44	196.42K
Mar 21, 2025	0.42	0.46	0.42	0.43	371.5K
Mar 20, 2025	0.48	0.49	0.43	0.43	170.94K
Mar 19, 2025	0.45	0.48	0.45	0.48	413.8K
Mar 18, 2025	0.47	0.48	0.45	0.46	270.57K
Mar 17, 2025	0.46	0.48	0.43	0.47	283.19K
Mar 14, 2025	0.45	0.49	0.42	0.43	196.9K
Mar 13, 2025	0.55	0.55	0.44	0.44	271.95K
Mar 12, 2025	0.52	0.53	0.50	0.50	146.62K
Mar 11, 2025	0.51	0.51	0.46	0.49	166.33K
Mar 10, 2025	0.52	0.58	0.49	0.49	218.48K
Mar 07, 2025	0.51	0.54	0.51	0.52	172.71K
Mar 06, 2025	0.50	0.53	0.50	0.52	194.59K

Contact Details

New York, NY 10036

United States

Website: https://www.ovidrx.comContact: 646 661 7661

About Company

Frequently Asked Questions

What is the current Ovid Therapeutics Inc. (OVID) stock price?

OVID's industry and sector of operation?

Who are the executives of OVID?

How OVID did perform over past 52-week?

OVID's closing price is 13.33% higher than its 52-week low of $0.30 where as its distance from 52-week high of $3.45 is -90.14%.

How many employees does OVID have?

Number of OVID employees currently stands at 23.

Link for OVID official website?

Official Website of OVID is: https://www.ovidrx.com

How do I contact OVID?

OVID could be contacted at phone 646 661 7661 and can also be accessed through its website. OVID operates from 1460 Broadway, New York, NY 10036, United States.

How many shares of OVID are traded daily?

OVID stock volume for the day was 154.65K shares. The average number of OVID shares traded daily for last 3 months was 431.99K.

What is the market cap of OVID currently?

The market value of OVID currently stands at $24.17M with its latest stock price at $0.34 and 71.08M of its shares outstanding.

Employees	23
Beta	0.29
Sales or Revenue	$391.70K
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	23
Beta	0.29
Sales or Revenue	$391.70K
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

OVID Company Profile and Key Details

Ovid Therapeutics Inc.

OVID Stock Price Chart

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions

OVID Stock Price Chart

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions